Detalles de la búsqueda
1.
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects.
Support Care Cancer
; 32(3): 202, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427111
2.
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Pathologica
; 116(1): 55-61, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482675
3.
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer.
Int J Mol Sci
; 25(1)2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203248
4.
A Systematic Review and a Meta-analysis of Randomized Controlled Trials' Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Curr Oncol Rep
; 24(11): 1633-1644, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953601
5.
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.
Future Oncol
; 17(7): 807-815, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508980
6.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31753727
7.
Darolutamide in Metastatic Prostate Cancer.
N Engl J Med
; 386(24): 2344, 2022 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704492
8.
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Eur J Nucl Med Mol Imaging
; 47(11): 2633-2638, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249345
9.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
Lancet
; 390(10109): 2266-2277, 2017 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28916371
10.
FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
BMC Cancer
; 18(1): 470, 2018 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29699528
11.
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
Acta Oncol
; 56(4): 555-562, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28068151
12.
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
Lancet Oncol
; 17(9): 1306-16, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27473888
13.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776493
14.
Metastatic castration-resistant prostate cancer: time for innovation.
Future Oncol
; 11(1): 91-106, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25572785
15.
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Future Oncol
; 10(6): 975-83, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295376
16.
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey.
Tumori
; 110(3): 174-185, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462772
17.
Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.
Cancer Treat Rev
; 127: 102745, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723394
18.
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma.
J Clin Med
; 13(2)2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38256441
19.
How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists.
Cancer Treat Rev
; 125: 102692, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492515
20.
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.
Clin Genitourin Cancer
; 22(2): 56-67.e16, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798164